Opportunities and challenges of pharmacotherapy for pulmonary arterial hypertension in children.

Abstract excerpt

Pediatric pulmonary hypertension (PAH) is a rare disease that carries a poor prognosis if left untreated. Although there are published guidelines for the treatment of children with pulmonary hypertension, due to the limited number of robust pediatric clinical trials, recommendations are often based on limited data or clinical experience. Furthermore, many practical aspects of care, particularly for the pediatric...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Calcium Channel Blockers
• Share to Familial Primary Pulmonary Hypertension